Clinical Trial Update: Hydroxychloroquine and Gefitinib to Treat Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is examining hydroxychloroquine in combination with gefitinib for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN